
Over 80 companies develop 90+ molecular glues, advancing treatments for cancer and other diseases.
DelveInsight reports a competitive landscape with 80+ companies developing over 90 molecular glue therapies targeting diseases like cancer, immunology, and neurodegeneration. These small molecules promote protein degradation to treat previously 'undr...

